Effect of 5-LOX/COX-2 common inhibitor DHDMBF30 on pancreatic cancer cell Capan2 | Zendy

Bo Zhang | Zendy; Chang-Liang Wang | Zendy; Wenhua Zhao | Zendy; Ming Lv | Zendy; Chunying Wang | Zendy; Weixia Zhong | Zendy; Wuyuan Zhou | Zendy; Wen-sheng Yu | Zendy; Yan Zhang | Zendy; Sheng Li | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of 5-LOX/COX-2 common inhibitor DHDMBF30 on pancreatic cancer cell Capan2

Author(s) -

Bo Zhang,

Chang-Liang Wang,

Wenhua Zhao,

Ming Lv,

Chunying Wang,

Weixia Zhong,

Wuyuan Zhou,

Wen-sheng Yu,

Yan Zhang,

Sheng Li

Publication year - 2008

Publication title -

world journal of gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.427

H-Index - 155

eISSN - 2219-2840

pISSN - 1007-9327

DOI - 10.3748/wjg.14.2494

Subject(s) - apoptosis , pancreatic cancer , cell growth , nude mouse , cell culture , transplantation , mtt assay , cancer research , chemistry , cancer , microbiology and biotechnology , medicine , biology , biochemistry , genetics

To study the effect of 5-lipoxygenase/cyclooxygenase-2 (5-LOX/COX-2) dual inhibitor 7-tert-butyl-2, 3-dihydro-3, 3-dimethyl substituted dihydrofuran 30 (DHDMBF30) on proliferation and apoptosis of the pancreatic cancer cell line Capan-2 and the effect of DHDMBF30 on human pancreatic cancer in a nude mouse model.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research